Transfusion is important part of modern medical practice, and can be bifurcate into autologous transfusion (or auto-transfusion) and allogenic transfusion. Autologous transfusion means collection and reinfusion of the patient’s own red blood cells. This is in opposite to allogenic blood transfusion where blood from anonymous donors is transfused to the recipient. Autologous transfusion reduces the need for allogenic transfusion.
According to study, autologous transfusion to be more cost-effective than allogeneic transfusion and that clinical outcomes are improved.
The global market for auto-transfusion devices is segmented on basis of techniques, application, end user and geography:
The global auto-transfusion devices market on the basis of technique can be segmented into Predeposit transfusion, Intraoperative haemodilution, Intraoperative and postoperative salvage.
The market has been further classified on the basis of application, including Cardiac, Vascular, Orthopedic, Trauma surgery, and Liver Transplantation. Where, usage of auto-transfusion systems are highly used in cardiac application followed by orthopedic.
On the basis of end user, the global auto-transfusion devices market has been segmented into Hospitals, Ambulatory Surgical Centers, Emergency Rooms, Nursing Homes and Other. Among these end users, hospitals holds the maximum share and expected to propagate at a high growth rate.
On the basis of regional presence, global auto-transfusion devices market are segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America remains dominant in the global auto-transfusion devices market due to increasing number of patient suffering from cardiovascular diseases, and increasing geriatric population, which leads to increasing number of operations and surgeries. Emerging markets such as MEA and Latin America are expected to see delayed growth.
In the majority of the developed countries, the adoption of auto-transfusion devices are emphasizing by government bodies due to risk of transfusion reaction and transmission of infection associated to blood. Some of the prominent manufacturers of auto-transfusion devices identified in this market are Fresenius Kabi, Haemonetics, LivaNova, Medtronic, Terumo, Advancis Surgical, etc.
The report covers exhaustive analysis on:
Regional analysis includes
Auto Transfusion Devices Market to be on a Scintillating Spree Post-Covid-19 Era
As per Persistence Market Research, the global auto transfusion devices market is slated to witness an unprecedented CAGR between 2020 and 2030.
The global auto transfusion devices market is being driven by prevalence of vascular and cardiac diseases, people preferring auto transfusion technique in place of allogeneic due to reduced risk of infection, increase in orthopaedic surgeries, and technological upgradations in developing auto transfusion devices.
At the same time, it needs to be noted that higher cost of these devices coupled with maintenance is expected to hamper the market.
Auto transfusion chest tubes are doing their job pretty well. Chest drain collection systems are endowed with optional auto transfusion canisters to connect to chest tube. The basic function of canisters is that of collecting shed blood. Once filled, they could be hung in blood bank as a blood bag. Their effectiveness is likely to drive the auto transfusion chest tube market going forward.
Some more Bites to Gather
Based on type, the auto transfusion devices market spans off pump and on pump transfusion devices. It is a known fact that auto transfusion devices get away with transfusion transmitted infection. That’s why, the growth of the market gets propelled.
The outbreak of covid-19 has accelerated the auto transfusion devices market due to plasma therapy being asked for. This scenario will continue further as well. So, no harm in concluding that auto transfusion devices market is unfazed by the ongoing pandemic.
North America leads the market owing to better infrastructure on the part of health. Europe stands second. Latin America, MEA, and the Asia-Pacific are also in the fray due to increase in awareness therein.
The key market participants include Brightwake, Stryker, Advancis Surgical, Medtronic, LivaNova, Fresenius Kabi, Getinge AB, Terumo, and Haemonetics.